Financial results - NOVATOR PHARMA S.R.L.

Financial Summary - Novator Pharma S.r.l.
Unique identification code: 39190563
Registration number: J2018005166407
Nace: 2110
Sales - Ron
-
Net Profit - Ron
-5.928
Employees
Open Account
Company Novator Pharma S.r.l. with Fiscal Code 39190563 recorded a turnover of 2024 of - , with a net profit of -5.928 and having an average number of employees of - . The company operates in the field of Fabricarea produselor farmaceutice de bază having the NACE code 2110.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Novator Pharma S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - 0 0 0 31.513 0 0 0
Total Income - EUR - - - 0 1.607 54 31.615 350 559.670 3.586
Total Expenses - EUR - - - 4.389 11.229 16.786 19.914 9.772 545.003 9.514
Gross Profit/Loss - EUR - - - -4.389 -9.621 -16.732 11.700 -9.422 14.667 -5.928
Net Profit/Loss - EUR - - - -4.389 -9.621 -16.732 11.385 -9.422 10.928 -5.928
Employees - - - 1 1 1 1 1 1 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Novator Pharma S.r.l.

Rating financiar

Financial Rating -
NOVATOR PHARMA S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Novator Pharma S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Novator Pharma S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Novator Pharma S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Novator Pharma S.r.l. - CUI 39190563

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - 149 378.605 420.272 478.901 506.696 140 668.405
Current Assets - - - 533 15.574 29.947 124.144 84.582 596.576 1.401.707
Inventories - - - 0 0 0 0 0 0 0
Receivables - - - 4 14.560 23.940 67.157 68.610 61.874 969.249
Cash - - - 528 1.014 6.008 56.987 15.972 534.702 32.634
Shareholders Funds - - - -4.174 7.359 -9.508 22.303 12.950 23.839 17.778
Social Capital - - - 215 21.284 20.884 40.636 40.762 40.639 40.412
Debts - - - 4.855 386.820 460.112 580.743 578.327 572.877 2.052.335
Income in Advance - - - 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "2110 - 2110"
CAEN Financial Year 2110
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 1.401.707 euro in 2024 which includes Inventories of 0 euro, Receivables of 969.249 euro and cash availability of 32.634 euro.
The company's Equity was valued at 17.778 euro, while total Liabilities amounted to 2.052.335 euro. Equity decreased by -5.928 euro, from 23.839 euro in 2023, to 17.778 in 2024.

Risk Reports Prices

Reviews - Novator Pharma S.r.l.

Comments - Novator Pharma S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.